ResMed, a global leader in health technology focusing on sleep and home-based care, has launched its AirSense 11 device in India. This next-generation Continuous Positive Airway Pressure (CPAP) device is designed to simplify therapy initiation and enhance adherence for individuals diagnosed with Obstructive Sleep Apnea (OSA), the company informed in a press statement on Wednesday.
Equipped with an array of advanced digital health features, the device aims to make starting and staying on CPAP therapy more accessible and effective for users.
The launch coincides with findings from the 2024 ResMed Global Sleep Survey, conducted across 17 markets worldwide. The survey revealed that 46 per cent of respondents reported being diagnosed with OSA, a condition that affects approximately 936 million people globally. Despite the high prevalence, 33 per cent of these respondents either avoided treatment altogether or resorted to self-help measures to address their sleep difficulties. OSA, the most common sleep-related breathing disorder, occurs when throat muscles relax and obstruct the airway, with snoring being a prevalent symptom.
To address these challenges, ResMed’s AirSense 11 incorporates features designed to support users at every stage of their therapy journey. The Personal Therapy Assistant provides step-by-step guidance for setup through the myAir app, reducing setup time and easing users into therapy. Care Check-In offers personalised feedback based on user responses, such as therapy satisfaction and sleep quality, which can also be monitored remotely by healthcare providers via the AirView platform. Additionally, the Test Drive feature allows users to explore different pressure levels, ensuring a comfortable acclimation process.
The device also boasts proprietary therapy algorithms, including a specialised “AutoSet for Her” mode tailored to women’s unique needs. Over-the-air software updates keep the device equipped with the latest features, ensuring improved user experience and therapy outcomes. Its sleek design and intuitive touchscreen interface further enhance usability, making AirSense™ 11 ResMed’s most advanced CPAP device yet.
With its integration into the myAir app, users can track various metrics, including therapy hours, sleep apnea events, and mask usage, while receiving coaching tips and real-time support directly to their phones. For clinicians, the AirView platform provides a secure, cloud-based system to monitor patients remotely, share clinical insights, and optimise treatment outcomes while reducing follow-up costs.
Commenting on the launch, Sandeep Gulati, General Manager of ResMed India and South Asia, said, “AirSense 11’s tailored features, along with our myAir app, empower individuals to start and stay on CPAP therapy, enabling better breathing, sleep, and overall quality of life. The importance of quality sleep cannot be overstated, and this device is a step forward in helping those with sleep apnea live healthier lives.”
_20250108163943_original_image_21.webp)
_20250108121431_original_image_5.webp)
